University of Manchester Featured PhD Programmes
King’s College London Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
University of Kent Featured PhD Programmes
University of Reading Featured PhD Programmes
"t"×
10 miles

t PhD Projects, Programs & Scholarships

We have 205 t PhD Projects, Programs & Scholarships

  • "t" ×
  • clear all
Order by 
Showing 1 to 10 of 205
  PhD In Infection & Immunity - Profiling superantigen-induced immunosupression of unconventional T cells during severe sepsis
  Dr J McLaren, Prof M Eberl, Prof D Price
Application Deadline: 27 February 2019
Sepsis is a life-threatening illness that is triggered by an exaggerated immune response to severe infection. This unbalanced reaction induces hyperinflammation, shock and organ dysfunction that forms the primary cause of death in hospitalised patients.
  MRC DiMeN Doctoral Training Partnership: Harnessing T cells to target brain metastases
  Dr M Lorger, Dr R Salmond, Prof J Newton-Bishop
Application Deadline: 21 January 2019
An MRC-funded PhD student position is available to explore how T cells can be harnessed to enhance the efficacy of immune checkpoint inhibitors in melanoma brain metastases.
  Understanding how tetraspanins and the ‘molecular scissor’ ADAM10 promote blood cancer
  Dr M Tomlinson, Dr F L Khanim
Application Deadline: 20 January 2019
Steve Briddon (University of Nottingham) 3rd supervisor. Nick Holliday (University of Nottingham) 4th supervisor. Introduction. T-cell acute lymphoblastic leukaemia (T-ALL) is an aggressive blood cancer that is in urgent need of more effective therapies.
  Targeting The Thymus To Improve Immune Recovery Following Stem Cell Transplantation For Cancer Treatment
  Prof G Anderson, Dr W Jenkinson
Applications accepted all year round
Background. The treatment of cancer frequently requires the transplantation of bone marrow to regenerate the immune system that is damaged following ablative therapy.
  Exploring the influence of treatment on CD4+ T-cell sub-populations in patients receiving biologic drugs for their inflammatory arthritis
  Prof A Barton, Dr D Plant, Dr S Viatte
Applications accepted all year round
Background. Tumour necrosis factor inhibitor (TNFi) therapy is ineffective for approximately 20% of rheumatoid arthritis (RA) patients and there is currently no way to predict which patients will not benefit.
  Machine Learning and Integrative Approaches in Immunology: Developing machine-learning and mathematical models to understand heterogeneity of response to personalised cancer immunotherapy
  Dr H Koohy, Prof V Cerundolo, Prof T Dong, Prof A Simmons
Application Deadline: 26 July 2019
Cancer immunology is an area of cancer research that is gaining tremendous momentum. However, responses to immunotherapy are heterogeneous and patient care could be substantially improved by better understanding of how and why responses to immunotherapeutic approaches vary in different patients.
  Harvard T.H. Chan School of Public Health Doctoral Programs
Harvard T.H. Chan School of Public Health brings together dedicated experts from every discipline to educate new generations of global health leaders and produce powerful ideas that can transform the lives of people everywhere.
  Novel drug target validation for treating Diabetes Mellitus (ref: SF18/APP/Soundararajan)
  Dr M Soundararajan
Applications accepted all year round
The important cellular entities responsible for fighting against infections in our body are the T cells. T cells are however also shown to play a central role in the development of autoimmune diseases (AIDs) as “T cell activation hijacking” is the major autoimmune reaction causing mechanism observed in several AIDs.
  Laser-free high-resolution localisation and dynamics microscopy in controlled complex cellular environments
  Dr J Bernadino de la Serna, Prof M Booth
Application Deadline: 25 January 2019
Keywords. Superresolution microscopy, live-cell single molecule imaging, cell sensing and remodelling dynamics, T cell Biology, Immunophysics and Immunoengineering.
  How is fate determined during T cell development, leukemogenesis and responses?
  Dr S. Russell
Applications accepted all year round
Understanding how cell fate programming works will lead to improved diagnostic and therapeutic opportunities for leukemia, and to improved immunotherapies for cancer and infectious disease.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.